Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia
SPU-26 Pain Management Using Ketamine Composition Action supports planned IND package submission to FDA for SP-26 ENGLEWOOD CLIFFS, NJ, March 27, 2023 -- Silo Pharma, Inc. , a... | March 27, 2023
United States Eric Weisblum Silo Pharma Inc Management Using Ketamine Pain Management Chief Executive Officer
Source: marketscreener.com